Shanghai Pharmaceuticals : REPLY SLIP FOR HOLDERS OF H SHARE ATTENDING THE 2019 SECOND H SHARE CLASS MEETING
October 31, 2019 at 05:52 am EDT
Share
上海醫藥集團股份有限公司
Shanghai Pharmaceuticals Holding Co., Ltd.*
(A joint stock company incorporated in the People's Republic of China with limited liability)
(Stock Code: 02607)
REPLY SLIP FOR HOLDERS OF H SHARE ATTENDING THE
2019 SECOND H SHARE CLASS MEETING
To: Shanghai Pharmaceuticals Holding Co., Ltd. (the "Company")
Name of shareholder and registered address (Note 1):
being registered holder of (Note 2)
H shares.
I/We intend to attend (in person or by proxy) the 2019 Second H Share Class Meeting to be held at Meeting Room 601, 6th Floor of Affiliated Building, Maple International Building Two, 450 Fenglin Road, Xuhui District, Shanghai, PRC on 18 December 2019 and any adjournment thereof immediately following the conclusion of the 2019 First Extraordinary General Meeting and the 2019 Second A Share Class Meeting of the Company and any adjournment thereof.
Signature of shareholder:
Name of shareholder:
Date:2019
Notes:
Please insert full name(s) (in Chinese or in English) and address(es) (as it is recorded in the register of members of the Company) in block letters.
Please insert the number of shares registered under your name(s).
For holders of H shares of the Company, the completed and signed reply slip should be delivered to the H Share Registrar of the Company, Computershare Hong Kong Investor Services Limited, at 17M Floor, Hopewell Centre, 183 Queen's Road East, Wan Chai, Hong Kong on or before 8 December 2019 in person or by mail. In order to attend and vote at the 2019 Second H Share Class Meeting, holders of H Shares of the Company should ensure that all transfer documents, accompanied by the relevant share certificates, are lodged with the Company's H Share registrar, Computershare Hong Kong Investor Services Limited, at Shops 1712-1716, 17th Floor, Hopewell Centre, 183 Queen's Road East, Wan Chai, Hong Kong not later than 16:30 on 9 December 2019.
For identification purpose only
Attachments
Original document
Permalink
Disclaimer
Shanghai Pharmaceuticals Holding Co. Ltd. published this content on 31 October 2019 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 31 October 2019 09:51:06 UTC
Shanghai Pharmaceuticals Holding Co Ltd is a China-based company principally engaged in pharmaceutical industry, distribution and retail business. The Company's products include innovative drugs, chemical drugs, traditional Chinese medicines and rare disease drugs. The Company's products are mainly used in the cardiovascular system, digestive tract and metabolism, systemic anti-infection, central nervous system, anti-tumor and immunomodulators, musculoskeletal system and respiratory system. In addition, the Company also provides medical logistics and warehousing services. The Company distributes its products both in the domestic market and to overseas markets.
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD 
